The Real Word Study of Albumin-binding Taxol for Lung Cancer Treatment
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Confirmed by Histopathology or Cytology of Lung cancer
Male or female patients .
Confirmed by Histopathology or Cytology of Lung Cancer
Patients should be voluntary to the trial and provide with signed informed consent
The researchers believe patients can benefit from the study.
Patients with a known history of allergic reactions and/or hypersensitivity attributed to Albumin-binding taxol or its accessories
Pregnant or lactating women
Patients with Albumin-binding taxol contraindications
Patients of doctors considered unsuitable for the trial